Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 1 Hepatitis 1 Colitis 1

Interventions

pembrolizumab 29 Nivolumab 29 Specimen Handling 24 Ipilimumab 19 Magnetic Resonance Spectroscopy 17 Biopsy 11 CTLA-4 Antigen 9 Opdualag 8 Cyclophosphamide 8 relatlimab 6 Paclitaxel 6 trametinib 5 fludarabine 5 cemiplimab 5 Carboplatin 5 fludarabine phosphate 4 dabrafenib 4 binimetinib 4 avelumab 4 HhAntag691 4 lifileucel 3 capivasertib 3 atezolizumab 3 aldesleukin 3 X-Rays 3 Temozolomide 3 Taxes 3 Surgical Procedures, Operative 3 Standard of Care 3 Pemetrexed 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

vedolizumab × Dermatologic × 30 days × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡